Anika Therapeutics, Inc. (ANIK) NASDAQ
15.21
+0.29(+1.94%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.21
+0.29(+1.94%)
Currency In USD
| Market Cap | 137.8M |
| Enterprise Value | 104.51M |
| P/E Ratio | -19.95 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 1.94 |
| Price/Book Ratio | 1.51 |
| Enterprise/Revenue | 1.65 |
| Enterprise/EBITDA | -45.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.1 |
| Operating Margin | -0.1 |
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
| Revenue | 112.82M |
| Revenue/Share | 7.9 |
| Gross Profit | 63.81M |
| EBITDA | -1.83M |
| Net Income | -10.88M |
| Diluted EPS | -0.76 |
| Total Cash | 57.48M |
| Total Cash/Share | 4.03 |
| Total Debt | 24.2M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 4.72 |
| Book Value Per Share | 10.05 |
| 52-Week Change | 8.95 |
| 52-Week High | 15.48 |
| 52-Week Low | 7.87 |
| Moving Average 50 Days | 12.39 |
| Moving Average 200 Days | 10.32 |
| Average Volume | 146,185 |
| Shares Outstanding | 14.42M |
| % Held by Institutions | 85.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |